CORCEPT THERAPEUTICS INC
CORT
84 insider filings · Latest: Oct 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Oct 16 10:24 PM | James N WilsonDirector | Sale | 10,000 | $114.81 | $1.1M | 1,054,543(I) | View → |
| Oct 2, 2026 | Oct 5 11:58 PM | Roberto Wandenkolk VieiraPresident, Oncology | Sale | 8,333 | $116.10 | $967.4K | 3,946(D) | View → |
| Oct 2, 2026 | Oct 5 11:54 PM | Joseph Douglas LyonChief Accounting & Technology Officer | Sale | 9,190 | $116.13 | $1.1M | 5,683(D) | View → |
| Oct 1, 2026 | Oct 5 11:54 PM | Joseph Douglas LyonChief Accounting & Technology Officer | Sale | 810 | $115.40 | $93.5K | 5,683(D) | View → |
| Oct 2, 2026 | Oct 5 11:49 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Sale | 24,587 | $116.28 | $2.9M | 9,938(D) | View → |
| Oct 1, 2026 | Oct 5 11:49 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Sale | 413 | $115.54 | $47.7K | 9,938(D) | View → |
| Oct 1, 2026 | Oct 1 3:09 PM | Lyon Joseph Douglas | Proposed Sale | 10,000 | $115.23 | $1.2M | — | View → |
| Sep 16, 2026 | Sep 18 11:53 PM | Roberto Wandenkolk VieiraPresident, Oncology | Sale | 296 | $100.82 | $29.8K | 3,946(D) | View → |
| Sep 14, 2026 | Sep 16 8:30 PM | Joseph Douglas LyonChief Accounting & Technology Officer | Sale | 10,000 | $113.49 | $1.1M | 5,683(D) | View → |
| Sep 15, 2026 | Sep 16 8:30 PM | James N WilsonDirector | Sale | 10,000 | $110.69 | $1.1M | 1,064,543(I) | View → |
| Sep 15, 2026 | Sep 15 2:23 PM | WILSON JAMES N | Proposed Sale | 30,000 | $111.48 | $3.3M | — | View → |
| Sep 14, 2026 | Sep 14 5:58 PM | Lyon Joseph Douglas | Proposed Sale | 10,000 | $113.44 | $1.1M | — | View → |
| Sep 1, 2026 | Sep 4 1:16 AM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Sale | 25,000 | $114.43 | $2.9M | 9,755(D) | View → |
| Sep 2, 2026 | Sep 4 1:02 AM | Roberto Wandenkolk VieiraPresident, Oncology | Sale | 58,333 | $110.76 | $6.5M | 4,242(D) | View → |
| Sep 2, 2026 | Sep 2 8:08 PM | Vieira Roberto Wandenkolk | Proposed Sale | 75,295 | $110.76 | $8.3M | — | View → |
| Aug 26, 2026 | Aug 28 8:30 PM | Kimberly ParkDirector | Sale | 26,685 | $122.55 | $3.3M | 0(D) | View → |
| Aug 25, 2026 | Aug 27 8:30 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Sale | 30,955 | $125.58 | $3.9M | 9,755(D) | View → |
| Aug 26, 2026 | Aug 26 8:14 PM | KIMBERLY PARK | Proposed Sale | 26,685 | $122.55 | $3.3M | — | View → |
| Aug 25, 2026 | Aug 25 9:24 PM | Maduck Sean | Proposed Sale | 175,000 | $125.58 | $22.0M | — | View → |
| Aug 18, 2026 | Aug 20 8:30 PM | David L MahoneyDirector | Sale | 103,606 | $118.25 | $12.3M | 1,133,539(I) | View → |
Page 1 of 8
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Mar 3 11:16 PM | Atabak MokariChief Financial Officer | Grant/Award | 140,000 | $35.70 | 140,000(D) | View → |
| Feb 27, 2026 | Mar 3 11:14 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Grant/Award | 140,000 | $35.70 | 140,000(D) | View → |
| Feb 27, 2026 | Mar 3 11:14 PM | Hazel HuntChief Scientific Officer | Grant/Award | 140,000 | $35.70 | 140,000(D) | View → |
| Feb 27, 2026 | Mar 3 11:13 PM | Gary Charles RobbChief Business Officer | Grant/Award | 140,000 | $35.70 | 140,000(D) | View → |
| Feb 27, 2026 | Mar 3 11:13 PM | William GuyerChief Development Officer | Grant/Award | 140,000 | $35.70 | 140,000(D) | View → |
| Feb 24, 2026 | Feb 26 9:45 PM | James N WilsonDirector | Option Exercise | 100,000 | $3.88 | 0(D) | View → |
| Feb 9, 2026 | Feb 11 10:26 PM | Hazel HuntChief Scientific Officer | Option Exercise | 150,000 | $3.88 | 0(D) | View → |
| Feb 3, 2026 | Feb 5 10:42 PM | William GuyerChief Development Officer | Option Exercise | 20,000 | $21.65 | 230,000(D) | View → |
| Jan 27, 2026 | Jan 29 9:10 PM | BAKER G LEONARD JRDirector | Option Exercise | 140,000 | $15.15 | 0(D) | View → |
← Previous
Page 3 of 3